Clinical manifestations are complex and often involve multi-systemic burdens. Early identification and standardised clinical care are essential for improving prognosis. Diagnosis of the disease requires a combination of clinical manifestations, imaging inspections, laboratory testing and pathological activation.
The platform can help align teams of authoritative experts at home and abroad to provide accurate diagnosis and treatment programs. Treatment and management of Wilson's neurotypes requires individualized development, typically including multidimensional management, including drug therapy, rehabilitation interventions, regular follow-up, and more. In recent years, with the development of therapeutic, immune-regulatory therapy and precision medicine, significant improvements have been made in many previously difficult-to-treat genetic metabolic disorders.
Treatment needs to be closely monitored for efficacy and adverse reactions, with timely adjustment according to disease changes. Multidisciplinary collaboration (MDT) is particularly important for the integrated management of Wilson's neurotypes. 2.
Visiting China: arranging face-to-face treatment with authoritative experts, developing individualized treatment plans; 3. Full-service: providing one-stop services such as medical translation, medical care, accommodation arrangements; 4. Long-term follow-up: establishing a chronic disease management archive, continuous monitoring of disease changes and treatment effects.